C37H48N6O5S2
Neat
720.95
-20°C
Room Temperature
4-Dehydroxy-5-hydroxy Ritonavir; 202816-62-4; Ritonavir 4-hydroxy isomer; UNII-QA8V47KHDS; QA8V47KHDS; Ritonavir impurity N [EP]; DTXSID40174138; 2, 7, 10, 12-Tetraazatridecanoic acid, 5-hydroxy-12-methyl-9-(1-methylethyl)-13-(2-(1-methylethyl)-4-thiazolyl)-8, 11-dioxo-3, 6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S, 5S, 6S, 9S)-; Thiazol-5-ylmethyl ((1S, 3S, 4S)-1-benzyl-3-hydroxy-4-(((2S)-3-methyl-2-((methyl((2-(1-methylethyl)thiazol-4-yl)methyl)carbamoyl)amino)butanoyl)amino)-5-phenylpentyl)carbamate; Thiazol-5-ylmethyl (2S, 4S, 5S)-4-hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido(-3-methylbutanamido)-1, 6-diphenylhexan-2-ylcarbamate; RITONAVIR IMPURITY N [EP IMPURITY]; Ritonavir impurity N; RITONAVIR IMPURITY N (EP IMPURITY); Ritonavir impurity, 4-hydroxy isomer-(USP); Ritonavir impurity, 4-hydroxy isomer-[USP]; RITONAVIR IMPURITY, 4-HYDROXY ISOMER-(USP IMPURITY); RITONAVIR IMPURITY and 4-HYDROXY ISOMER-[USP IMPURITY]; RefChem:179515; DTXCID2096629; Ritonavir EP Impurity N
1, 3-thiazol-5-ylmethyl N-[(2S, 4S, 5S)-4-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1, 3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1 and 6-diphenylhexan-2-yl]carbamate
InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(39-29)25(3)4)34(45)41-31(17-27-14-10-7-11-15-27)32(44)18-28(16-26-12-8-6-9-13-26)40-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,40,47)(H,41,45)(H,42,46)/t28-,31-,32-,33-/m0/s1